×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SSMXY – sysmex corp unsp/asdr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SSMXY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
08:13 pm
ssmxy
Asia-Pacific Liquid Biopsy Market Research Report 2024-2033: Increasing Product Launches in the Market and Growing Funding by the Key Players in the Market [Yahoo! Finance]
Low
Report
Asia-Pacific Liquid Biopsy Market Research Report 2024-2033: Increasing Product Launches in the Market and Growing Funding by the Key Players in the Market [Yahoo! Finance]
3/3
05:24 pm
ssmxy
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320 [Yahoo! Finance]
Neutral
Report
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320 [Yahoo! Finance]
3/3
05:16 pm
ssmxy
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320 [Globe and Mail, The (Toronto, Canada)]
Neutral
Report
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320 [Globe and Mail, The (Toronto, Canada)]
3/3
04:58 pm
ssmxy
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320
Neutral
Report
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320
3/3
10:46 am
ssmxy
CHICAGO NAMED #1 U.S. METRO FOR CORPORATE RELOCATION FOR 12TH CONSECUTIVE YEAR [Yahoo! Finance]
Low
Report
CHICAGO NAMED #1 U.S. METRO FOR CORPORATE RELOCATION FOR 12TH CONSECUTIVE YEAR [Yahoo! Finance]
2/19
10:32 am
ssmxy
ULTRA RED Reports Triple Growth in 2024, Strengthening Its Position as a CTEM Leader [Yahoo! Finance]
Low
Report
ULTRA RED Reports Triple Growth in 2024, Strengthening Its Position as a CTEM Leader [Yahoo! Finance]
2/7
08:32 am
ssmxy
Opportunities in Malaysia's $2+ Billion Diagnostic Labs Market, 2025-2030 - West Malaysia Dominates with Infrastructure and Investments Shaping the Market [Yahoo! Finance]
Low
Report
Opportunities in Malaysia's $2+ Billion Diagnostic Labs Market, 2025-2030 - West Malaysia Dominates with Infrastructure and Investments Shaping the Market [Yahoo! Finance]
1/15
08:26 am
ssmxy
Sysmex America Expands Operations with Plans for New Reagent Manufacturing, Distribution and Service Center in Brazil [Yahoo! Finance]
Low
Report
Sysmex America Expands Operations with Plans for New Reagent Manufacturing, Distribution and Service Center in Brazil [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/29
SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.
1.2%
11/14 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 0.6%
12/5 Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex [Forbes] 0.1%
11/14 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 0.6%
12/5 Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex [Forbes] 0.1%
TOP News Decliners
8/5
Trade war fears, stronger yen topple Japanese shares to 2-month lows [Reuters]
-7.2%
4/16 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at Citigroup Inc from a "neutral" rating to a "sell" rating. -6.5%
2/15 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.7%
11/8 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -3.1%
11/26 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. -1.9%
10/1 Knowledge Is Power - Celebrating 10 Years of Sysmex Academy and More -1.6%
9/9 Sysmex Europe GmbH wins the Silver Award for 'Best Customer Training Program' in Excellence in Learning Awards -0.6%
9/16 Sysmex America Joins Clinical Lab 2.0 Movement to Support Collaboration Around Value-Based Healthcare -0.1%
4/16 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at Citigroup Inc from a "neutral" rating to a "sell" rating. -6.5%
2/15 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.7%
11/8 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -3.1%
11/26 SYSMEX CORP/ADR (OTCMKTS: SSMXY) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. -1.9%
10/1 Knowledge Is Power - Celebrating 10 Years of Sysmex Academy and More -1.6%
9/9 Sysmex Europe GmbH wins the Silver Award for 'Best Customer Training Program' in Excellence in Learning Awards -0.6%
9/16 Sysmex America Joins Clinical Lab 2.0 Movement to Support Collaboration Around Value-Based Healthcare -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: